| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 09/30/2004 | WO2004082720A1 Drug for treating hemophilia and method of treating hemophilia using the same |
| 09/30/2004 | WO2004082622A2 Retinoid replacements and opsin agonists and methods for the use thereof |
| 09/30/2004 | WO2004082564A2 Coated enzyme granules |
| 09/30/2004 | WO2004082463A2 Folate receptor gene modulation for cancer diagnosis and therapy |
| 09/30/2004 | WO2004082458A2 Tyrosine kinome |
| 09/30/2004 | WO2004082369A1 Reduced stature plants |
| 09/30/2004 | WO2004074445A9 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/30/2004 | WO2004073603A3 Dna vaccine that expresses mutant adp-ribosyltransferase toxins which display reduced, or are devoid of, adp-ribosyltransferase activity |
| 09/30/2004 | WO2004072221A3 Proteases |
| 09/30/2004 | WO2004052275A3 Methods of producing lignin peroxidase and its use in skin and hair lightening |
| 09/30/2004 | WO2004037194A3 Novel compositions with chitinase activity |
| 09/30/2004 | WO2004020467A3 Novel mucin binding polypeptides derived from lactobacillus johnsonii |
| 09/30/2004 | WO2004017910A3 Total synthesis of heparin |
| 09/30/2004 | WO2004005317A3 Thrombin peptide derivative dimers |
| 09/30/2004 | WO2003062447A3 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 09/30/2004 | WO2003050084A3 Kinases and phosphatases |
| 09/30/2004 | WO2003031930A3 A phosphatase associated with metastasis |
| 09/30/2004 | US20040194166 Transgenic tobacco plant comprising nucleotide sequences coding thyroid-stimulating hormone or gonadotrophin-receptor for use in treatment of reproductive disorders; bioreactors and therapeutic polypeptides |
| 09/30/2004 | US20040194163 GTP binding stress-related proteins and methods of use in plants |
| 09/30/2004 | US20040194155 Comprises hepatitis b viral nucleotide sequences coding mutant reverse transcriptase for use in developing antibodies to prevent or treat hepatitis viral infection; immunotherapy; |
| 09/30/2004 | US20040193921 Systems and methods for authenticating a user to a web server |
| 09/30/2004 | US20040192895 Extracting plant protein from defatted jojoba meal comprising forming aqueous dispersion with defatted jojoba meal, filtering, drying and recovering plant protein permeate; cosmetics nutraceutical |
| 09/30/2004 | US20040192580 Regulation of human ceramide kinase |
| 09/30/2004 | US20040191926 Ptp1b inhibitors and ligands |
| 09/30/2004 | US20040191911 Method for altering degradation of engineered protein in plant cells |
| 09/30/2004 | US20040191898 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy |
| 09/30/2004 | US20040191883 Comprises water soluble glucose dehydrogenase associated with pyrroloquinoline quinine as a coenzyme for use as diagnostic tool in bioassay for monitoring blood glucose concentration |
| 09/30/2004 | US20040191882 Generating glucose oxidase immobilized glass beads; obtain beads, silanize, heat, expose to gluteraldehyde and heat resistant oxidase, recover conjugated beads |
| 09/30/2004 | US20040191875 Method for producing target substance |
| 09/30/2004 | US20040191870 Methods of 6-0 sulfating polysaccharides and 6-0 sulfated polysaccharide preparations |
| 09/30/2004 | US20040191867 DNA sequences coding for a mammalian glucuronyl C5-epimerase and a process for its production |
| 09/30/2004 | US20040191864 Methods for producing biological substances in enzyme-deficient mutants of Aspergillus |
| 09/30/2004 | US20040191861 Preparing transgenic cells and inducing expression of heterologous sequences; tissue engineering and in vitro translation |
| 09/30/2004 | US20040191838 Sulfonyl ester compound for modifying catalase catalytic activity in order to determine microbial contamination of foodstuffs and cooling lubricants; screening efficacy of biocides |
| 09/30/2004 | US20040191826 Dipeptidyl peptidases |
| 09/30/2004 | US20040191825 Using pyrococcus polymerase fusion to replicate preferential nucleotide sequences; polynucleotide amplification tool; genetic engineering |
| 09/30/2004 | US20040191820 Using high throughput assay for detection and identification of modulators of telomeric complex binding activity; diagnosis and treatment of cell proliferative and age related disorders; antiproliferative agent |
| 09/30/2004 | US20040191811 Methods for measuring levels of uridine-diphosphate-N-acetylglucosamine and activity of inhibitors thereof |
| 09/30/2004 | US20040191787 Leucoanthocyanidin reductase (LAR) polypeptide for modifying the pasture quality of legumes and producing bloat-safe forage crops with enhanced nutritional value, disease/pest resistance and malting qualities |
| 09/30/2004 | US20040191773 Oligoribonucleotides and ribonucleases for cleaving RNA |
| 09/30/2004 | US20040191763 HBV mutations associated with reduced susceptibility to adefovir |
| 09/30/2004 | US20040191759 Identifying modulators which decrease genic expression from site-1 protease regulatory sequences; modulators for treatment of cardiovascular, diabetic and obesity disorders; gene expression inhibition |
| 09/30/2004 | US20040191335 Filtering aqueous dispersion of defatted meal and hydrolyzing with protease enzymes; producing high molecular weight retentate fraction |
| 09/30/2004 | US20040191285 Unhydrolyzed jojoba protein products having high simmondsin concentration and methods of producing the same |
| 09/30/2004 | US20040191271 Crystal structures of streptococcus undecaprenyl pyrophosphate synthase and uses thereof |
| 09/30/2004 | US20040191220 Gene expression inhibition of the WWP1 gene or neutralization of expression products to promote cell death; antiapoptosis and anticarcinogenic agents; medical diagnosis and prognosis |
| 09/30/2004 | US20040189124 Axial load-insensitive emergency bearing |
| 09/30/2004 | US20040188353 Novel separation agent for separating optical isomer and method for preparation thereof |
| 09/30/2004 | DE10312842A1 Thermisch stabile Amidasen Thermally stable amidases |
| 09/30/2004 | CA2790689A1 Fvii or fviia variants |
| 09/30/2004 | CA2743539A1 Angiotensin-converting enzyme inhibitory peptides |
| 09/30/2004 | CA2743313A1 Angiotensin-converting enzyme inhibitory peptides |
| 09/30/2004 | CA2519633A1 R-hydroxynitrile lyases having improved substrate acceptance and the use thereof |
| 09/30/2004 | CA2519456A1 Aberrantly methylated genes in pancreatic cancer |
| 09/30/2004 | CA2519397A1 Reduced stature plants |
| 09/30/2004 | CA2519258A1 Construct comprising region recognized by antibody against von willebrand factor-specific cleaving protease |
| 09/30/2004 | CA2519020A1 Method for the production of gla-residue containing serine proteases |
| 09/30/2004 | CA2518655A1 Retinoid replacements and opsin agonists and methods for the use thereof |
| 09/29/2004 | EP1462524A1 Cellulase preparations containing reducing agent and method of processing fiber |
| 09/29/2004 | EP1462523A2 L-glutamic acid-producing bacterium and method for producing L-glutamic acid |
| 09/29/2004 | EP1462522A2 Maize Met-1 promoter |
| 09/29/2004 | EP1462516A1 Mutated 6-phosphogluconate dehydrogenase |
| 09/29/2004 | EP1462456A1 Tumor antigens |
| 09/29/2004 | EP1462102A1 A method for promoting gonadal growth in an animal |
| 09/29/2004 | EP1461758A2 Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof |
| 09/29/2004 | EP1461621A2 Enzyme activity profiles |
| 09/29/2004 | EP1461610A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use |
| 09/29/2004 | EP1461460A2 Methods for the identification of inhibitors of asparagine synthase, 5-aminolevulinate synthase, histidinol-phosphatase, 3-isopropylmalate and threonine synthase as antibiotics |
| 09/29/2004 | EP1461446A2 Lipid-associated molecules |
| 09/29/2004 | EP1461435A1 A reporter gene |
| 09/29/2004 | EP1461434A2 Compositions, methods and systems for discovery of lipopeptides |
| 09/29/2004 | EP1461431A2 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters |
| 09/29/2004 | EP1461426A1 Eubacterial rna-polymerase mutants with altered product production |
| 09/29/2004 | EP1461425A2 Novel human hydroxylases and polynucleotides encoding the same |
| 09/29/2004 | EP1461409A2 Subtilisin variants with improved characteristics |
| 09/29/2004 | EP1461359A2 Novel anti-igf-ir antibodies and uses thereof |
| 09/29/2004 | EP1461357A2 Novel hev antigenic peptide and methods |
| 09/29/2004 | EP1461073A2 Peptide agonists of prostate-specific antigen, and uses therefor |
| 09/29/2004 | EP1461072A1 Proteases producing an altered immunological response and methods of making and using the same |
| 09/29/2004 | EP1322750A4 Proteolysis targeting chimeric pharmaceutical |
| 09/29/2004 | EP1218488A4 Site-specific recombination system to manipulate the plastid genome of higher plants |
| 09/29/2004 | EP1141328B1 Recombinant bacterial strains for the production of natural nucleosides and modified analogues thereof |
| 09/29/2004 | EP1042463B1 Target for treating atherosclerosis, obesity and type ii diabetes |
| 09/29/2004 | EP1019496B1 In vitro sorting method |
| 09/29/2004 | EP0994942A4 Improved promoters for enhancing plant productivity |
| 09/29/2004 | EP0956045B1 Assembly-deficient herpesvirus vaccine |
| 09/29/2004 | EP0914417B1 Human dnase ii |
| 09/29/2004 | EP0913467B1 Mesophilic xylanases |
| 09/29/2004 | EP0912754B1 Process for the fermentative production of deacylated cephalosporins |
| 09/29/2004 | EP0815857B1 Antiobestic agent containing procyanidin as the active ingredient |
| 09/29/2004 | CN1533439A Process for preparing L-amino acids using strains of enterobascteriaceae family which contain an atteuated aspa gene |
| 09/29/2004 | CN1533437A DNA sequences for regulating transcription |
| 09/29/2004 | CN1533279A Organo-phosphorous compounds for activating gamma/delta T-cells |
| 09/29/2004 | CN1168829C Calcium free subtilisin mutants |
| 09/29/2004 | CN1168824C Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pulvialis for biosynthesis of astaxanthin |
| 09/29/2004 | CN1168499C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 09/29/2004 | CN1168492C Use of activated protein C in porducing medicine and unit formulation containing activated protein C |
| 09/29/2004 | CN1168463C Injection for treating cerebral thrombus and preparation thereof |
| 09/28/2004 | US6797861 Seed shattering |
| 09/28/2004 | US6797859 Vascular tissue preferred promoters |